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Abstract

The number of people in the world living with Alzheimer’s Disease and related
dementias (ADRD) continues to rise rapidly, which places a substantial burden on people with
dementia (PWD), their families, and the society. Such a burden has been rising faster in lowincome and middle-income countries (LMIC) where around two-thirds of PWD live. While prior
research documents dementia prevalence in China and indicates its large geographic disparities,
no study to date has documented the national pattern of health care utilization, quality and costs
in China. The absence of knowledge would largely impede the effective allocation of resources
for combating dementia and targeted policy interventions in China. This study made the first
attempt to document inpatient care utilization, quality, and costs for ADRD patients in China
using a nationally representative inpatient database. We first summarized geographic disparities
in dementia prevalence in China, which was compared with disparities in care utilization and
outcomes among hospitalized patients. We then explored to what extent demographic factors,
insurance generosity, comorbidities, hospital infrastructure may explain variations in inpatient
care utilization, quality and costs for dementia patients. Our findings suggest gaps in health
equity and efficiency for this fast-growing population of dementia patients. Our results inform
future work to improve chronic disease management and health insurance coverage to achieve a
more affordable and equitable financial burden for PWD.
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Health Care Utilization and Costs for Dementia Patients in China: Evidence
from A National Inpatient Database
1. Introduction
Around 50 million people in the world live with dementia, and this number is projected to
rise rapidly to 152 million by 2050.1 Dementia has placed a substantial burden on patients, their
families, and the society. Compared to cognitively intact older adults, persons with dementia
(PWD) have a larger burden of chronic conditions that interact with dementia to incur higher
medical costs.2,3,4 PWD have larger incidence rate of all-cause hospitalization and worse physical
function than cognitively intact older adults after hospital discharge.5,6 PWD may experience
lower quality of life, impaired decision-making ability, and financial insecurity.7,8 PWD access
more long-term services and support (LTSS),9 and their families and communities bear
considerable informal care costs and financial costs due to increasing demand for care workers.
Considering both the direct health costs and indirect costs of labor force, the global costs of
dementia are estimated at about US$1 trillion annually.10
Disease burden for dementia has been rising in low-income and middle-income countries
(LMIC) where around two-thirds of PWD live. Numbers of PWD in LMIC are rising faster than
in their high-income counterparts, because of greater increases in life expectancy.1 The
challenges from increasing numbers of PWD is especially serious in China, the most populous
and fastest aging country. The overall prevalence of dementia is 6.0%, representing 15.07
million PWD aged 60 years or older.11
While prior research documents dementia prevalence in China and indicates its large
geographic disparities across regions,12 no study to date has documented the national pattern of
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health care access and utilization in China. The absence of knowledge would largely impede
effective allocation of resources to combat dementia and target policy interventions in China.
Prior studies in other countries suggest large disparities in access to and use of health care for
PWD.13 For instance, individuals' health insurance status may present a barrier to accessing care:
the under-insured may have lower reimbursement rates along with higher premiums and
deductibles. Admission from the emergency room (ER) is an access measurement metric that
may indicate such disparities. Disparities in care access and utilization may also exist in many
other aspects outside the health care system. In particular, social, economic and environmental
factors such as socioeconomic status, age, gender, disability status, and geographic location (and
associated gaps in diagnosis and treatment capacity) may all contribute to perpetuating
disadvantages in care resources. For example, while prevalence of dementia is higher in females,
chances of inpatient care for males with dementia are higher than that for females in the U.S.14
Meanwhile, few studies have documented dementia inpatient care quality and costs in
China. Better understanding characteristics of hospitalized dementia patients, such as their
composition, severity of conditions and care outcomes, will help guide future responses to
improve quality. The growing medical cost of dementia care around the globe prompts us to
understand the main drivers of cost variations and provides policy makers targets to leverage
future improvement efforts. As disparities in costs of dementia may exist in multiple
dimensions,15 we document geographic disparities of inpatient costs among dementia patients in
China, followed by estimating disparities in dementia inpatient costs by province, gender, age,
health insurance, job type, and comorbidities.
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2. Methods
2.1 Data Source/Classification/Sampling (Bias)
Using a nationally representative inpatient medical records data, we document access,
quality and cost of inpatient care for PWD in China. Our selected group of dementia patients in
this study is unique in two aspects. First, the latest overall prevalence of dementia in China was
6.0% ,11 but only a small portion of patients get hospitalized. Documenting the national patterns
of hospitalization would provide valuable insights because low hospitalization rates may suggest
inadequate dementia awareness, diagnosis, and treatment. We also document various disparities
in access to care using categories of demographic and socioeconomic variables such as gender
and insurance types. Second, due to the underdevelopment of long-term care in China,16 the
demand for health care and nursing care can be intertwined. Utilization of this nationally
representative data will clarify the gaps and composition difference between the population
diagnosed for dementia and the smaller group of patients who get hospitalized for dementia.
The inpatient medical records data are obtained from Aden Technology, a large
healthcare data company that keeps collecting, cleaning and analyzing medical records data for
over 3,000 hospitals in China. The national sample covers 29 provinces, making it a nationallyrepresentative sample of inpatient health care records in China. This dataset provides rich
information about every anonymous patient including: age, gender, job type, insurance type,
admission type, admission time, hospital level, main diagnosis, and secondary diagnosis.
We extracted dementia medical records where the main diagnosis corresponds with one
of the 24 ICD-10 matched from a set of ICD-9 codes used to define dementia in existing U.S.
literature (Appendix Table 1). Medical records from patients under 65 years of age were omitted
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because of the lower risk of dementia, and that 65 years of age is a common cutoff used in
existing literature. The date of medical records was limited to the time window of June 2017 to
June 2019 to reflect recent care patterns. A respective 2% of the highest and lowest total
inpatient care costs were excluded from this analysis. Our results are robust to removing extreme
costs using other sample selection criteria.
The final total number of medical records included in this study was 51,530
(corresponding to 15,694 patients) as shown in Figure 1. This sample of 51,530 included
inpatient medical records of dementia patients across 29 provinces or regions in China. The
database is nationally representative, the sampling seemed not biased by observable social,
economic, demographic conditions (Appendix Figure 1).

Figure 1. Study flowchart for dementia medical records (N=51,530)
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Figure 2. Distribution of Medical Records by Common Causes of Dementia
Notes: G30=Alzheimer’s disease; F01=vascular dementia; Other Gs (G31, G91, other G)= Dementia with Lewy
bodies, or other degenerative diseases of nervous system; F03=unspecified dementia; Other Fs (F06, other F=other
mental disorders due to brain damage and dysfunction and to physical disease).

The final sample of dementia medical records include 17,819 (34.6%) Alzheimer’s
disease (G30), 11,554 (22.4%) Vascular dementia (F01), 9,790 (19%) Lewy body disease or
other degenerative diseases of nervous system (G31, G91, and other Gs), 4,947 (9.6%) other
mental disorders due to brain damage and dysfunction and to physical disease (F06 and other
Fs), and 6,111 (11.9%) unspecified dementia (F03).

2.2 Covariates and Outcomes
Table 1 displays the characteristics of the patient medical records. These measures were
later included in our regression analysis as independent variables: patient demographic
characteristics (age and sex), insurance type (UEBMI, URBMI, NCMS, Private, full subsidy,
self-pay, other), job type (retired/unemployed, farmer, other), major comorbidity (cerebral
infarction, heart disease, hypertension, lung disease, diabetes, other mental disorders, other
comorbidities), admission type (outpatient, ER, other), and hospital level (In a descending order:
class 3 grade A, class 3 grade B, class 2 grade A, class 2 grade B and below, others) from the
medical records. Focusing on the major secondary diagnosis listed on each medical record, we
identified six categories of most frequent comorbidities. Cerebral infarction is the leading
7

comorbidity in our study sample (15,078; 29.3%) , followed by hypertension (4,970; 9.6%) and
heart disease (3,113; 6.0%). Finally, ER admission is an indicator of disease severity and might
imply difference in health management. U.S. evidence has shown that rural PWD had higher
adjusted odds of going to the ED for a preventable visit compared with urban patients. 17Urban
patients may have better access to care.
Number of hospital admission due to dementia-related illness per 100,000 person-year is
an alternative utilization metric. It is calculated using our medical records data along with data
from China Statistical Yearbook for hospital admission and provincial population. With our
dataset, we obtained a ratio between the 51,530 dementia records and all inpatient records
available in the same time window. We then referred to real-world hospital admission data from
the 2017 China Statistical Yearbook to scale up our total number of dementia records. Using the
provincial permanent resident population as the denominator, we calculated the number of
hospital admission due to dementia-related illness, per 100,000 person-year.
Care outcomes are some directly measurable parts of care quality. We documented two
metrics for quality and outcome measurement, length of stay (LOS) and in-hospital mortality
rate. These are lenses through which we could obtain initial estimates of the outcome and quality
of inpatient dementia care across Chinese provinces.

Table 1. Characteristics of the dementia medical records
Characteristics

No. (%)

Descriptions

Average inpatient
costs (CNY) (Std.
Dev.)

Panel A
Sample Population

51,530

Age band
65-69

8,621 (16.7%)

10,878.4 (12,357.8)
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70-74

9,518 (18.5%)

10,754.6 (11,513.4)

75-79

10,528 (20.4%)

10,870.3 (10,695.3)

80-84

10,921 (21.2%)

12,215.2 (12,268.2)

85-89

8,130 (15.8%)

16,475.2 (15,795.5)

90-94

3,129 (6.1%)

18,529.2 (15,692.4)

95+

683 (1.3%)

19,709 (16,548.5)

Male

27,726 (53.8%)

12,975.6 (13,464)

Female

23,804 (46.2%)

12,175.6 (12,532.6)

Farmer

9,153 (18.2%)

8,706.6 (10,537.7)

Retired/Unemployed

22,384 (44.6%)

14,348.2 (14,124.9)

Other

18,670 (37.2%)

12,244.6 (12,134.4)

Sex

Occupation

Insurance type
UEBMI

23,140 (48.3%)

Urban Employee Basic
Medical Insurance covers
employees in private and
state-owned enterprises,
government, social
organizations, and
nonprofits.

13,044.6 (12,389.8)

URBMI

7,487 (15.6%)

Urban Resident Basic
Medical Insurance covers
the informal labor and the
urban employed not
covered by UEBMI.

10,676 (11,226.5)

NCMS

6,387 (13.3%)

New Cooperative Medical
Scheme provides lowcost, basic health services
for the rural population.

8,718.3 (10,417.8)

Private

216 (0.5%)

Private Health Insurance.

13,428.9 (13,803.8)

Self-Pay

3,587 (7.5%)

Fully out-of-pocket

12,689 (15,460.4)
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Full subsidy

2,822 (5.9%)

Other insurance

4,281 (9.9%)

Full coverage (or “free
care”), exclusively for
eligible civil servants,
provides the largest scope
of coverage and the
highest reimbursement
rate.

20,891 (16,906.3)

13,656.6 (14,949.1)

Comorbidities
Cerebral infarction

15,078 (29.3%)

I61, I63, I67 and I69

11,857.4 (111,337.3)

Hypertension

4,970 (9.6%)

I10

11,812.8 (112,856.8)

Heart disease

3,113 (6.0%)

I25

14,307.4 (14,919.1)

Diabetes

1,677 (3.3%)

E11 and E14

12,784.2(12,859.3)

Lung disease

1,433 (2.8%)

J98

17,540.5 (16,226.6)

Mental disorders

1,670 (3.2%)

F

13,606.4 (12,872.4)

Other comorbidities

23,589 (45.8%)

13,263.9 (12,672.4)

Emergency room

10,404 (21.2%)

12,949 (13,161.3)

Outpatient

35,777 (72.9%)

12,399.9 (12,886.2)

Other

2,898 (5.9%)

Other admission types
such as transfer from
another hospital

10,436.8 (11,018.8)

Class III grade A

28,531 (55.4%)

Tertiary hospitals, level A
(Highest level)

14,169 (13,990.7)

Class III grade B

2,824 (5.5%)

Tertiary hospitals, level B

11,339.9 (12,711.6)

Class II grade A

13,332 (25.9%)

Secondary hospitals, level
A

10,426.2 (11,413.4)

Class II grade B and

936 (1.8%)

Secondary hospitals in
level B, and primary
hospitals (similar to
community hospitals)

7,469.5 (9,806)

Other hospital

5,907 (11.5%)

Admission type

Hospital level

below

11,359.4 (11,118.6)
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Season
Spring

15,579 (30.2%)

12,539.2 (12,891.7)

Summer

11,847 (23%)

11,884.4 (12,323.9)

Fall

10,726 (20.8%)

12,063.5 (12,301.3)

Winter

13,378 (26%)

13,741.75
(14,288.1)

Panel B
Outcomes

Mean (Std. Dev.)

Descriptions

Min/Max

Length of Stay

20.38 (37.18)

in days

1/206

Daily cost

987.66 (1,091.25)

CNY

2.18/63,830.22

Total cost

12,425.48
(13,287.64)

CNY

336/95,503.25

2.3 Statistical Analysis
Statistical analyses were performed using STATA software (release 16.0, Stata Corp)
with two-sided tests of significance. Basic characteristics of dementia medical records in our
study sample was presented with average total inpatient costs. We calculated Moran’s I statistic
(using distance decay parameter 2) for the number of hospital admission due to dementia-related
illness, percentage of ER admissions, adjusted logarithmic inpatient cost, average number of
comorbidities, in-hospital mortality, and average LOS, to investigate spatial autocorrelation.
In the descriptive analysis, average total inpatient costs in each province was adjusted for
age and sex. Our regression analysis estimated four multivariable linear models with the outcome
variables being logarithmic (log) total cost, log daily cost, total cost, and length of stay (LOS),
respectively. All four models used a same set of independent variables, including age and
gender, hospital level and type of admission , comorbidities, patient insurance type, job type,
length of stay (omitted when dependent variable is LOS). Seasonality was adjusted for using a
11

set of season dummy variables. Reference groups for these categories of characteristics are: male
patients, patients aged 65-69, level 3A (best) hospitals, patients admitted through outpatient,
patients with lung disease, patients with patients with full subsidy, and farmers. The model also
included province-by-year dummy variables to adjust for province-specific time trends over the
sampling period. The assumptions of constant variance and normal distribution of the error terms
in the linear regression models were checked by examining plots of the residuals versus fitted
values and normal probability plots of the residuals. To ensure that the residuals are
independently and identically distributed, we obtained robust cluster estimators. The standard
error adjusted for within province-year autocorrelations (for a total of 87 province-year clusters,
29 provinces times 3 years).

3. Results
3.1 Inpatient Care Incidence and ER Admission
The national average number of admissions due to dementia-related illness was 54.3 per
100,000 person-year. Figure 3 shows that the number of dementia-related admissions was higher
in western and southern provinces.
Being admitted through the emergency room (ER) suggests an acute condition at
admission and may incur higher total costs. 10,404 (21.2%) of all dementia medical records were
ER admissions. A geographical distribution of the percentage of ER admission over provinces
(figure 4) reveals that western provinces had a higher rate of ER admissions. The correlation
between the number of hospital admissions per province and the percentage of ER admissions
per province was -0.37 (p<0.001).
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Figure 3. Number of hospital admission due to dementia, per 100,000 person-year.
Notes: Calculated by scaling up the total number of dementia hospital admission data using the ratio of hospital
admission records in the sampled national database to the total number in the 2017 China Statistical Yearbook.
Finally, the provincial-level population size was used to calculate hospital admissions per 100,000 person-year.
Moran’s I statistic for the number of hospital admission due to dementia-related illness is 0.03 (p=0.48), when
distance decay parameter is 2. The cutoff points for legend in the map correspond to 25%, 50% and 75% percentiles.
No data from Tibet, Hong Kong, Macau and Taiwan were included in the study.

Figure 4. Proportion of dementia Patients Admitted through ER (by Province)
Notes: Moran’s I statistic for percentage of ER admissions is 0.02 (p=0.58), when distance decay parameter is 2.
The cutoff points for legend in the map were defined according to 25%, 50% and 75% percentile values. No data
from Tibet, Hong Kong, Macau and Taiwan were included in the study.
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An investigation of ER utilization by major insurance types was explored to investigate
equity problems between patients of different insurance types. NCMS, URBMI, UEBMI and full
insurance were compared. These four major insurance types accounted for 42,821 (83.1%)
inpatient records. The proportion of patients admitted from the ER was lower for more generous
insurance types. In particular, under NCMS, rural dementia patients were most likely to be
admitted through ER, while those covered by full insurance were least likely to be admitted
through ER (Appendix Figure 2).

3.2 Inpatient Care Quality and Outcomes
Understanding comorbidities is vital because PWD may struggle managing their
coexisting conditions, and these conditions are often the primary cause of inpatient
hospitalization. When the main diagnosis in our study sample is one of dementia conditions, a
patient can have up to 15 comorbidities listed in the medical record, and the average number of
comorbidities listed was 5.2. A visual representation of average number of comorbidities over
provinces is shown in figure 5 Panel A. Patients in western provinces generally had more
comorbidities. According to correlation between metrics by province in figure 5 Panel D, higher
average number of comorbidities significantly drove up LOS, but it did not necessarily lead to
higher in-hospital mortality rate (Panel E).
In-hospital mortality measures care quality. Among all hospital admissions in our
analytical sample (51,530 person-years), the overall in-hospital mortality rate was 0.62%. As
Panel B suggests, in-hospital mortality tended to be higher in northern provinces, including
Heilongjiang, Jilin, Liaoning and Inner Mongolia. Some provinces in middle China also
indicated high in-hospital mortality.
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The average LOS in China was 20.4 days during our study periods. As shown in Panel C,
southern provinces were about 13-23 days, and two additional provinces showed exceptionally
high LOS(23-30 days). The LOS displayed highly significant spatial autocorrelation. The
Moran’s I lay in the range from 0.35-0.55, when we increased distance decay parameters from 2
to 4 and 6. Distance decay parameter is a crucial aspect of Moran’s I, larger distance decay
parameters indicate that the degree of spatial dependence between geographic areas decrease
rapidly when the distance between them increases.

Panel A. Average number of comorbidities in dementia patients

15

Panel B. In-hospital mortality Rate

Panel C. Length of stay (days) per admission
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Panel D. Correlation between average number of comorbidities and LOS.

Panel E. Correlation between average number of comorbidities and in-hospital mortality rate
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Panel F. Correlation between LOS and in-hospital mortality.
Figure 5. Inpatient Care quality and Outcomes
Notes: Panel A shows the provincial level average number of comorbidities. Total number of comorbidities in
medical records range from 0 to 15. Moran’s I statistic for average number of comorbidities is 0.04 (p=0.39), when
distance decay parameter is 2. Panel B shows provincial level in-hospital mortality rate. Moran’s I statistic for
percentage of in-hospital mortality is -0.02 (p= 0.82), when distance decay parameter is 2. Panel C shows the
provincial level average LOS per admission. Moran’s I statistic for average LOS is 0.35 (p<0.001), when distance
decay parameter is 2. The cutoff points for legend in the maps were defined according to 25%, 50% and 75%
percentile values. Panel D, E and F show correlation between the above three care quality and outcome metrics,
along with significance levels noted in the legend. No data from Tibet, Hong Kong, Macau and Taiwan were
included in the study.

3.3 Explaining Variations in Inpatient Care Cost
The national average cost of dementia inpatient care per admission was 12425.48 RMB.
Total hospitalization costs were higher in eastern provinces, such as Beijing, Shanghai, Jiangsu
and Fujian (Figure 6).
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Figure 6. Log total cost after adjusting for age and gender
Notes: Moran’s I statistic is 0.19 (p=0.015), when distance decay parameter is 2. The cutoff points for legend in the
map were defined according to 25%, 50% and 75% percentile values. No data from Tibet, Hong Kong, Macau and
Taiwan were included in the study.

Figure 7. Regression Estimates Plot for (1) log total cost (2) log daily total cost
Notes: Regression models included gender, age, hospital level, insurance types, major comorbidities, job type,
admission type, length of stay, seasons, controlled for province-year fixed effects, and used robust cluster
estimators. The standard error adjusted for within province-year autocorrelations (for a total of 87 province-year
clusters, 29 provinces times 3 years).
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Panel A. Log total inpatient costs after adjusting for all covariates.

Panel B. Log daily inpatient costs after adjusting for all covariates.
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Panel C. Absolute total costs after adjusting for all covariates from regression

Panel D. Absolute daily costs after adjusting for all covariates from regression
Figure 8: Total cost and daily cost after adjusting for all variables from regression
Notes: Panel A shows the log total costs after adjusting for all covariates from regression. Panel B shows log daily
inpatient costs after adjusting for all covariates from regression. Reference province used in Panel A and B is
Hunan. Panel C shows the absolute total costs after adjusting for all covariates from regression. Panel D shows
absolute daily costs after adjusting for all covariates from regression. The cutoff points for legend in the maps were
defined according to 25%, 50% and 75% percentile values. Currency used in Panel C and D is CNY.
No data from Tibet, Hong Kong, Macau and Taiwan were included in the study.
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Figure 7 displays results for the fully adjusted regression models of log-total cost and logdaily total cost. There was a diverging trend over age groups between the sequence of
coefficients from log-total cost and log-daily cost. As age increases, coefficients from log-total
cost regression tend to change from negative to positive, while coefficients from log-daily cost
become lower and lower under zero. Specifically, using patients between age 65 and 69 as
reference, patients between 90 and 94 years old had 18.6% (95% CI, 10.2% to 27%; p<.001)
higher total cost, but 5.9% (95% CI, -10.7% to -1.1%; p=.02) lower daily total cost. An
additional day of stay led to 0.96% (95%CI, 0.81% to 1.1%; p<0.001) higher total cost, and
0.76% (95%CI, -0.83% to -0.69%; p<0.001) lower daily costs. When compared with patients
who have lung disease (J98), patients with all other comorbidities have significantly lower total
cost and daily total costs. Patients with hypertension had 33% (95% CI, -39.3% to -26.7%;
p<.001) lower total costs, and this is the comorbidity group with lowest total costs relative to
lung disease. Patients with diabetes had 27.9% (95% CI, -35.3% to -20.6%; p<0.001) lower total
costs relative to patients with lung disease. In terms of absolute monetary costs, our total costs
per inpatient admission after adjusting for all covariates ranged from 12,109.5 (CNY) for
hypertension to 16,836.2 (CNY) for lung disease.
Compared with level 3 grade 1 (tertiary) hospitals, both total cost and daily total cost
decreased for lower level hospitals. Total costs and daily total costs at hospitals of class 2 grade 2
or lower were 59.6% (95% CI, -70.2% to -49%; p<.001) and 59.4% (95% CI, -71.2% to -47.8%;
p<.001) lower than that for the best hospitals.
Compared with farmers, patients who are retired or unemployed had 16.7% (95% CI,
12.9%-20.6%; p< .001) higher total costs. Using full subsidy insurance type as our reference, all
patients of all other insurance types had significantly lower total cost. Patients with self-pay had
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43.9% (95% CI, -59.3% to -28.4%; p<.001) lower total costs; patients with NCMS (rural) had
38.2% (95% CI, -51.4% to -25%; p<.001) lower total costs.
Figure 8 shows provincial variations of total cost and daily cost after adjusting for all
variables from the regression, in both logarithmic and absolute costs. After all the adjustments,
absolute total costs were highest in Beijing, Tianjin, Fujian, Shanghai, Guizhou and Zhejiang.
Most of these provinces are along the east coast.

Figure 9. Regression Estimates Plot for LOS model.
Notes: Regression models included gender, age, hospital level, insurance types, major comorbidities, job type,
admission type, seasons, controlled for province-year fixed effects, and used robust cluster estimators. The standard
error adjusted for within province-year autocorrelations (for a total of 87 province-year clusters, 29 provinces times
3 years).

Figure 9 displays the regression results for the length of stay. As age increases, length of
stay has an increasing trend. Compared with patients of 65-69 years old, patients aged between
90 and 94 years stayed 9.2 (95% CI, 4.37 to 14.03; p<.001) days longer. Similarly, people who
are retired or unemployed stayed 5.1 (95% CI, 2.8 to 7.47; p<.001) days longer, when compared
with farmers. Using full subsidy as the reference group, patients with NCMS had the shortest
23

length of stay, they stayed 8.3 (95% CI, -12.62 to -4.01; p< .001) days shorter than the reference.
There was no significant LOS difference for patients with UEBMI, private insurance and selfpay.
Patients at the lowest level hospitals (Level 2B and below) had no significant difference
in the LOS relative to those hospitalized at tertiary hospitals. Using lung disease as reference,
patients with cerebral infarction stayed 3.4 (95% CI, -5.3 to -1.55; p<0.001) days shorter,
patients with heart disease stayed 8.7 (95% CI, 0.89 to 16.62; p=0.03) days longer, patients with
diabetes stayed 1.6 (95% CI, 0.25 to 2.96; p=0.02) longer. Other categories of comorbidities did
not introduce significantly different LOS.

4. Discussion
Our study revealed stark differences between dementia prevalence and inpatient care
utilization rate across China, as well as differences in demographic and socioeconomic
characteristics among PWD. The extent of population aging, economic and health infrastructure
development and their regional disparities, lack of understanding of the disease, and chronic
disease management may account for these differences. The feelings of stigma and individuals’
financial difficulties may impede utilization of care.11 Inadequate primary care system and near
absence of a long-term care system in China limit options for PWD.
We first interpret total inpatient costs and its determinants with a focus on comorbidities,
along with the relationship between LOS and the same set of covariates. Then, we address two
major findings about insurance types, regarding total inpatient costs and the percentage of ER
admissions. Moreover, evidence regarding in-hospital mortality provides incentive for future
improvements in monitoring and health management. Finally, we discuss the correlations among
the quality, outcome, and cost measures, focusing on the positive correlation between number of
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comorbidities and LOS. We end the discussion with implications, potential future directions for
researchers, and limitations.
In this nationally-representative study of inpatients with dementia, the major
determinants of inpatient cost variations included age, insurance type, comorbidities, and
hospital level. As expected, older age, higher reimbursement rate, and inpatient admission at
higher level hospitals were all associated with higher inpatient costs. As age increased, total
inpatient cost increased but daily inpatient cost decreased. This divergence may be driven by
older patients staying longer but receiving less intensive treatment and care.
When the primary diagnosis was dementia, we studied all comorbidities listed as the first
secondary diagnosis in the medical records, among which six were most frequent. Of the six
major comorbidities, lung disease and cerebral infarction contributed the most to higher total
inpatient costs. Note that a substantial proportion of our study sample (29.3%) had cerebral
infarction: this is not surprising because cerebrovascular diseases such as stroke may have
directly stimulated cognitive or behavioral problems. Cerebral infarction can introduce
apparently abnormal symptoms, which are reasons for healthcare-seeking and sometimes
immediate inpatient admission. Hypertension, one significant underlying cause of stroke, was the
second most frequent comorbidity in our study sample (9.6%), though inpatient costs for patients
with hypertension were lowest among categories of patients with the six major comorbidities.
Our findings regarding costs were consistent with prior literature in the U.S. setting15 in that
cerebral infarction was a top-ranked comorbidity that signaled higher costs for patients. Our
finding that hypertension signaled lower total costs relative to all other major comorbidities was
also congruent with the U.S. findings,15 where direct medical costs from hypertension was
significantly lower than costs from stroke, diabetes and heart disease. Our absolute average
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inpatient costs per admission, though overall lower, were not directly comparable with the U.S.
study because the latter investigated annual direct medical costs for each comorbidity of
multimorbid PWD.
LOS increased for those 80 and older; it was longest for patients aged between 90 and 94
years old. Patients with URBMI, NCMS and self-pay had shorter LOS relative to patients with
full subsidy. Among the major comorbidities, patients with heart disease had the longest LOS.
Heart disease was a unique comorbidity because although it was not associated with the highest
inpatient costs among the six comorbidities, patients with heart disease had the longest LOS
among these major comorbidity types. This finding may inform the design of interventions to
improve heart disease management in an outpatient setting and reduce the use of health resources
in hospital settings.
Our study offered two major findings about insurance type. First, relative to patients with
full subsidy (or “free care”), patients with all other major insurance types had lower total
inpatient costs. Overall, higher reimbursement rates were associated with higher inpatient costs
in our study sample. More generous insurance types may have created incentives for higher
medical spending. Park et al.18 found that dementia beneficiaries in the U.S. Medicare Advantage
(MA) had lower costs than those in Traditional Medicare (TM). MA typically had more generous
benefits and lower cost-sharing, and it was a pathway to provide more efficient care without
lowering care quality.19 The U.S. experiences imply the potential to leverage insurance in health
management to contain medical spending, without compromising dementia care quality in China.
Moreover, examination of the proportion of ER admissions by major insurance types uncovered
potential disparities in health management and care access. Among the four major insurance
types NCMS, URBMI, UEBMI and full subsidy, the percentage of patients admitted from ER
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was highest in patients with NCMS and lowest in patients with full subsidy. This implies that for
more generous insurance types, the percentage of patients admitted from the ER decreased. The
largest proportion of ER admissions in NCMS may indicate delayed disease management, as
well as inadequate rural health infrastructures for rural patients. We interpreted results
recognizing that China’s health system is unique from other countries because of the lack of care
“gatekeeper”. ERs are mandated to maintain a primary responsibility system and are not allowed
to deny any ER patients regardless of the reasons.20 ER admission in China is a patient-driven
factor. Besides patient preferences at the start of hospitalizations, hospital-level and provincelevel policies regarding inpatient admission processes are also drivers or ER admission. These
factors may be explored in future studies to uncover more implications behind the variation of
ER admission across insurance types, and across geographic regions.
Our study revealed some positive correlation between the number of comorbidities and
in-hospital mortality (figure 5). Golüke et al. assessed the risk factors for in-hospital mortality for
dementia patients in the Netherlands, and found that male sex, older age, living with a partner
(compared with patients living alone), acute admission and Alzheimer’s Disease are the most
significant risk factors.21 Findings from this strand of literature stress the importance of
identifying patients at hospital admissions to reduce risk of unfavorable outcomes.
Finally, our study revealed provincial differences in costs and interrelationships between
the care outcome and utilization metrics. Regarding inpatient costs, after adjusting for all
covariates, total inpatient costs were significantly higher in eastern provinces Shanghai, Jiangsu,
Zhejiang, Guangdong, Hebei and Beijing, when compared with Hunan (figure 8). However,
these provinces with highest total inpatient costs did not necessarily have the highest daily
inpatient costs. Total inpatient costs, a combination of daily inpatient costs and LOS,
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demonstrate a different pattern from daily inpatient costs. Our maps of China also demonstrated
meaningful interrelationships between average number of comorbidities, average LOS, inhospital mortality, percentage of emergency room admission and costs. First, higher average
number of comorbidities was positively and significantly correlated with longer average LOS but
not increased ER admission, in-hospital mortality, or costs. Second, although the overall
significant correlation indicated that higher number of comorbidities led to longer average LOS,
the pattern was of different levels across provinces. For example, Hainan had the third highest
average number of comorbidities, but it had a relatively low average LOS. In short, observation
of the interrelationships between maps revealed variation between disease management across
provinces.
Our findings have three main implications. First, identifying chronic conditions that
significantly increase costs is crucial for the design of future policies or interventions. Our study
suggests that future policies or interventions to contain costs from chronic conditions should
target diabetes, heart disease, and cerebral infarction, but a greater range of chronic conditions
needs to be studied. Second, regarding the fact that the rate of ER admission is lowest for
patients with the most generous insurance type, health insurance is a possible pathway to
promote chronic disease prevention and control. Third, the number of chronic diseases is
strongly correlated with the use of health care resources, but the provincial variation in average
number of comorbidities and LOS reflect differences in health management efficiency. This area
deserves future analyses to explore the mechanisms behind geographic differences in disease
management and facilitate their mutual learning.
Future research may also explore ambulatory care sensitive conditions which could
reduce ER visits that contribute to the monetary costs of dementia. Those potential explorations
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will help point out the current problems, and find out ways for future strategies to simultaneously
consider ER admission rates, mortality and costs to find a balance for dementia care. Besides
delving into the ER visits for dementia as a primary diagnosis, one might further analyze medical
records with dementia as a secondary diagnosis and also those without dementia. After
controlling for the conditions, one may observe the inpatient cost differences between patients
with and without dementia, either as primary or secondary relative to those without dementia.
The 2019 U.S.-based Alzheimer’s Association Report22 documented the impact of dementia on
the use and costs for health care in people with coexisting conditions, finding that the presence of
dementia largely increases total Medicare payments, especially for patients with coronary heart
diseases and diabetes. Using Chinese inpatient data for analogous exploration will further fill the
gap in dementia literature and provide opportunities for some international comparisons.
Our study had some limitations. First, we only included medical records that have
dementia as the primary diagnosis to ensure that medical costs are directly related to dementia,
but selection bias may exist. The diagnosis of dementia is heterogeneous across the country and
may vary by level of hospital. The data quality may depend on the training of the healthcare
professional overseeing the case. Lower level hospitals may not have psychiatrist geriatricians
making the dementia diagnosis. Second, there may exist coding errors regarding the diagnosis of
dementia. Not all dementia patients get one of the dementia codes as a primary diagnosis,
possibly due to the complications from other comorbidities such as cerebral infarction.
Additionally, we only had broad categories of chronic conditions, which did not allow us to
differentiate within disease categories or analyze other conditions. Finally, because of the
differences in access across the population, there exists a gap between the hospitalized patients in
our sample and the overall group of dementia patients in China.
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5. Conclusions
This study makes the first attempt to document inpatient care utilization, quality and costs
for dementia patients in China using a nationally-representative inpatient database. We first
summarized geographic disparities in dementia prevalence in China, which was compared with
disparities in care utilization and outcomes among hospitalized patients. We then explored to
what extent demographic factors, insurance coverage, common comorbidities, hospital
infrastructure may be associated with variations in inpatient care costs for dementia patients. Our
findings suggest gaps in health equity and efficiency for this fast-growing population of
dementia patients. Our results inform future work to improve chronic disease management and
health insurance coverage to achieve a more affordable and equitable financial burden for PWD,
their families and the society.
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Appendices & Supplemental Materials
Appendix Figure 1
Panel A: Scatter plot, percentage of people above high school education vs. Number of hospital
admission due to dementia-related illness, per 100,000 person-year

Panel B: Scatter plot, percentage of people above high school education vs. Percentage of
emergency room admissions in dementia medical records (%)

Panel C: Scatter plot, GDP per capita vs. Percentage of emergency room admissions in dementia
medical records (%)
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Notes: [1]Beijing and Shanghai were excluded from this analysis because data from these two major cities tend to be
outliers, potentially leading to biased results. [2] Our data is immune from selections from social, economic, and
demographic indicators. We combined two indicators available in our data with external variables extracted from
China Statistical Yearbook 20191 to observe the correlations. The observed outcomes are the number of hospital
admission due to dementia-related illness per 100,000 person-year, and the percentage of dementia emergency
admission among all inpatient admissions (%). Social, economic, and demographic indicators include GDP per
capita, number of hospital beds per 100,000 people, percentage of people above high school education (%), share of
elderly above age 65 (%), and the elderly dependency ratio (%). All the data were collected at the province level and
weighted by the population size over 65 years of age in each province to account for the different representation
between regions.
[3] All correlation between macro covariates and the two indicators (Number of hospital admission due to dementiarelated illness, per 100,000 person-year, and Percentage of dementia emergency admission (%)) are insignificant at
the province level. The correlation between percentage of people above high school education and number of
hospital admission due to dementia-related illness, per 100,000 person-year is -0.29 (p = 0.14) (Panel A). The
correlation between percentage of people above high school education and percentage of emergency admissions in
dementia records is 0.23 (p = 0.23) (Panel B), but the correlation between GDP per capita and percentage of
emergency admissions in dementia records is -0.26 (p = 0.18) (Panel C). Higher GDP per capita suggests lower
percentage of emergency admission.

1

China Statistical Yearbook http://www.stats.gov.cn/tjsj/ndsj/2019/indexch.htm
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Appendix Figure 2: Proportion of dementia Emergency Room (ER) Admissions Across
Four Main Insurance Types

Notes: NCMS=New Cooperative Medical Scheme; URBMI=Urban Resident Basic Medical Insurance;
UEBMI=Urban Employee Basic Medical Insurance; Full Subsidy=full coverage (“free care”). Insurance generosity
increases from the left to the right.

Appendix Figure 3: Proportion of dementia patients with Each of the Six Major Diagnosed
Comorbidities

Notes: Data displayed in this figure only utilize the first comorbidity diagnosis code, which tends to be in most
severe condition in addition to the main diagnosed disease - dementia. The top six nominated comorbidities
extracted from the first comorbidity diagnosis code were used in this visualization.
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Appendix Figure 4: Composition of insurance types, by age group

Appendix Figure 5: Proportion of ER Admissions among dementia patients, by age

group

Appendix Figure 6: Regression results for Total Inpatient Costs (Estimates Plot, in CNY)
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Appendix Table 1: ICD-9 Codes for Dementia Diagnoses
Type of Diagnosis

ICD-9 Codes

Dementia (Alzheimer’s disease and related
dementias)

331.0, 331.11, 331.19, 331.2, 331.7, 290.0,
290.10, 290.11, 290.12, 290.13, 290.20,
290.21, 290.3, 290.40, 290.41, 290.42,
290.43, 294.0, 294.10, 294.11, 294.20,
294.21, 294.8, 797

Appendix Table 2: Testing Provincial Level Spatial Autocorrelation in Key Measures of
Inpatient Care Utilization and Costs (Moran’s I statistic, by distance decay parameter)
I
parameter=2
Average number of 0.04 (p=0.39)
comorbidities

parameter=4

parameter=6

0.07 (p=0.5)

0.09 (p=0.5)
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In-hospital Mortality -0.02 (p=0.82)

-0.01 (p=0.85)

-0.008 (p=0.85)

Average LOS

0.52*** (p<0.001)

0.55** (p=0.002)

Hospital admissions 0.03(p=0.48)
per 100,000 personyear

0.071 (p=0.52)

0.073 (p=0.57)

Percentage
emergency
admissions

0.06 (p=0.57)

0.07 (p=0.6)

0.3* (p=0.043)

0.32 (p=0.056)

0.35*** (p<0.001)

of 0.02 (p=0.58)
room

Adjusted logarithmic 0.19* (p=0.015)
inpatient cost

Notes: The logarithmic cost adjusted for age and gender.

Appendix Table 3: Full regression results for log-total cost and log-daily cost (point
estimate, 95%CI)
Characteristics

Point Estimate (95% CI)
Log-Total
Cost

Log-Daily Total
Cost

Total Cost
(CNY)

LOS (days)

65-69

Reference

Reference

Reference

Reference

70-74

-0.01 (-0.04,
0.01)

-0.03 (-0.05, 0.01)

-323.67 (714.16, 66.82)

0.26 (-1.25, 1.77)

75-79

-0.03 (-0.05,
-0.01)

-0.05 (-0.07, 0.03)

-688.77 (1123.22, 254.32)

1.12 (-0.81, 3.04)

80-84

-0.001 (-0.03,
0.03)

-0.05 (-0.08, 0.02)

-372.87 (841.39, 95.65)

4.3 (1.52, 7.07)

85-89

0.11 (0.06,
0.17)

-0.05 (-0.09, 0.01)

1777.91(795.57
, 2760.25)

7.15 (3.69, 10.62)

90-94

0.19 (0.1,
0.27)

-0.06 (-0.11, 0.01)

2455.66(1002,
3909.31)

9.2 (4.37, 14.03)

95+

0.21 (0.08,
0.35)

-0.09 (-0.18, 0.01)

3140.68(1074.6
5, 5206.71)

7.87 (3.7, 12.05)

Age band
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Sex
Female (Yes=1)

-0.05 (-0.06,
-0.03)

-0.08 (-0.1, 0.06)

-1055.38(1331.66, 779.1)

3.99 (2.53, 5.44)

Reference

Reference

Reference

Reference

Occupation
Farmer
Retired/Unemployed

0.17 (0.13,
0.21)

-0.05 (-0.1, 0.004)

1424.97 (856.48,
1993.46)

5.13 (2.8, 7.47)

Other

0.09 (0.04,
0.13)

-0.13 (-0.2, 0.07)

-101.99 (-618.7,
414.73)

9.03 (5.1, 12.97)

Insurance type
Full Subsidy

Reference

Reference

Reference

Reference

UEBMI

-0.2 (-0.32, 0.08)

-0.07 (-0.18,
0.04)

-4640.46 (7362.58, 1918.34)

1.68(-3.11, 6.48)

URBMI

-0.29 (-0.42, 0.17)

-0.04 (-0.15,
0.07)

-4933.75 (7675.2, -2192.3)

-5.79 (-9.72, -1.85)

NCMS

-0.38 (-0.51, 0.25)

-0.03 (-0.14,
0.08)

-5132.64 (7673.95, 2591.32)

-8.31 (-12.62, 4.01)

Private

-0.36 (-0.56, 0.16)

-0.23 (-0.47,
0.01)

-5794.46 (9857.45, 1731.47)

5.4 (-2.89, 13.69)

Self-Pay

-0.44 (-0.59, 0.28)

-0.2 (-0.35, 0.05)

-4199.25 (6844.79, 1553.71)

-4.2 (-8.42, 0.03)

Other insurance

-0.22 (-0.36, 0.07)

-0.01 (-0.13,
0.11)

-2686.91 (5445.45, 71.63)

-3.5 (-8.12, 1.12)

Reference

Reference

-4077.36 (5264.13, -2890.6)

-3.43 (-5.3, -1.55)

Comorbidities
Lung disease

Reference

Cerebral infarction

-0.23 (-0.29, 0.17)

Reference
-0.19 (-0.25, 0.13)
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Hypertension

-0.33 (-0.39, 0.27)

-0.22 (-0.26, 0.18)

-4756.68 (5983.89, 3529.46)

-1.5 (-3.68, 0.68)

Heart disease

-0.26 (-0.33, 0.19)

-0.26 (-0.32,
0.21)

-3821.15 (5166.37,
2475.92)

8.76 (0.89, 16.62)

Diabetes

-0.28 (-0.35, 0.21)

-0.26 (-0.33,
0.2)

-4321.52 (5590.83, -3052.2)

1.6 (0.25, 2.95)

-0.25 (-0.32, 0.18)

-0.25 (-0.32, 0.18)

-4211.86 (5464.8, 2958.93)

2.86 (-0.84, 6.56)

-0.28 (-0.35, 0.21)

-0.2 (-0.25, 0.15)

-3903.36 (5199.45, 2607.28)

1.82 (-0.9, 4.54)

Reference

Reference

Other mental
disorders

Other Comorbidities

Admission type
Outpatient

Reference

Reference

Emergency room

0.11 (0.06, 0.16)

0.14 (0.04, 0.24)

1403.62 (549,
2258.23)

-1.91 (-4.79, 0.96)

Other

0.01 (-0.06,
0.08)

0.03 (-0.07, 0.13)

342.55 (-394.42,
1079.52)

-1.8 (-8.78, 5.19)

Hospital level
Class III grade A

Reference

Reference

Class III grade B

-0.24 (-0.34, 0.15)

-0.24 (-0.37, 0.12)

-3120.21 (4648.08, 1592.34)

5.44 (1.33, 9.55)

Class II grade A

-0.4 (-0.46, 0.36)

-0.42 (-0.49, 0.36)

-5358.88 (6162.53, 4495.23)

15.56 (2.86, 28.26)

Class II grade B and

-0.6 (-0.7, -0.49)

-0.6 (-0.71, -0.48)

-5793.67 (7198.53, -4388.81)

3.19 (-2.65, 9.03)

Other hospital

-0.23 (-0.32, 0.14)

-0.14 (-0.3,
0.03)

-3149.24(4252.38, -2046.1)

5 (-6.64, 16.64)

0.01 (0.008,
0.01)

-0.01 (-0.008, 0.007)

171.85 (142.19,
201.5)

n/a

below

Length of stay(days)

Reference

Reference
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Season
Spring

Reference

Reference

Reference

Summer

-0.01 (-0.04,
0.01)

0.01 (-0.01,
0.03)

35.05 (-328.12,
398.23)

-2.01 (-7.93, 3.9)

Fall

0.004 (-0.02,
0.03)

0.01 (-0.03,
0.05)

258.38 (-154.92,
671.67)

-4.5 (-14.99, 5.98)

Winter

-0.01 (-0.06,
0.03)

0.03 (-0.02,
0.08)

120.97 (-344.05,
586)

4.92 (1.71, 8.13)

Intercept

9.3 (9.14,
9.49)

7.14 (6.97,
7.31)

16142.07
(12513.66,
19770.48)

20.6 (10.33, 30.88)

Number of Obs

47,861

47,861

47,861

47,861

Notes: NCMS=New Cooperative Medical Scheme; URBMI=Urban Resident Basic Medical Insurance;
UEBMI=Urban Employee Basic Medical Insurance; Full Subsidy=full coverage (“free care”). Insurance generosity
increases from the left to the right.
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